BioSpace News Archive

Kinaxis® Inc., the leading supply chain management platform, was selected by F.I.S. - Fabbrica Italiana Sintetici S.p.A. to enable concurrent planning in its supply chain.

Organ Recovery Systems is honored to announce that its LifePort Liver Transporter was selected as the winner in the ‘Health’ category in Fast Company’s Innovation by Design Awards for 2023.

Acurx Pharmaceuticals, Inc. announced today that David P. Luci , President & CEO, will present at the H.C. Wainwright 25th Annual Global Investment Conference.

Matinas BioPharma announces that University of Minnesota Medical School researchers published results from the Phase 2 EnACT trial evaluating MAT2203 for the treatment of cryptococcal meningitis as a Major Article and Editor’s Choice in Clinical Infectious Diseases.

60 Degrees Pharmaceuticals today announced that the United States Patent and Trademark Office (USPTO) has awarded 60P a patent covering the use of tafenoquine for prevention of Plasmodium falciparum malaria.

Eli Lilly and Company (NYSE: LLY) today announced topline results from the LIBRETTO-531 study evaluating Retevmo versus physician’s choice of the multikinase inhibitors (MKIs) cabozantinib or vandetanib as an initial treatment for patients with advanced or metastatic rearranged during transfection (RET) -mutant medullary thyroid cancer (MTC).

Cabaletta Bio, Inc. today announced that it has entered into certain work orders relating to Good Manufacturing Practice (GMP) manufacturing under its existing master services agreement with WuXi Advanced Therapies (WuXi ATU), a global Contract Testing, Development and Manufacturing Organization (CTDMO).

PROCEPT BioRobotics® Corporation (NASDAQ: PRCT) (“PROCEPT BioRobotics”), a global leader in surgical robotics, announced today that it has successfully completed the first commercial Aquablation® therapy procedures in Japan.

Longeveron Inc. announced that the subscription period for its previously announced rights offering has begun.

Reflect Scientific, Inc., a leading provider of advanced cryogenic cooling solutions, is pleased to announce the receipt of a substantial order worth $200,000 from a major Bio-Pharma customer for its state-of-the-art Blast Freezers.